BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6207842)

  • 1. [RNA polymerase-rifamycin. A molecular model of inhibition].
    Chertov OIu; Obukhov AN; Lipkin VM
    Bioorg Khim; 1983 May; 9(5):633-40. PubMed ID: 6207842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the effect of different rifamycins on bacterial cell metabolism and on the RNA-polymerase reaction in a cell-free system].
    Subbotina NA
    Antibiotiki; 1978 Mar; 23(3):239-42. PubMed ID: 345958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Escherichia coli RNA polymerase defective in transcription due to its overproduction of abortive initiation products.
    Jin DJ; Turnbough CL
    J Mol Biol; 1994 Feb; 236(1):72-80. PubMed ID: 7508986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R17 RNA replicase. V. Rifamycin sensitivity of R17 RNA synthesis in vivo.
    Igarashi SJ; Elliott FB
    J Biochem; 1975 Jun; 77(6):1261-9. PubMed ID: 773921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physico-chemical properties of DNA-dependent RNA-polymerase from Escherichia coli and its subunits].
    Deshko TN; Kudelina IA; Surin AM
    Bioorg Khim; 1984 May; 10(5):641-7. PubMed ID: 6388581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of isolated yeast and mycelial phase RNA polymerases of Histoplasma capsulatum by rifamycin derivatives.
    McMillian R; Medoff G; Schlessinger D; Kobayashi GS
    Sabouraudia; 1977 Nov; 15(3):257-61. PubMed ID: 601661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bacterial DNA-binding protein H-NS represses ribosomal RNA transcription by trapping RNA polymerase in the initiation complex.
    Schröder O; Wagner R
    J Mol Biol; 2000 May; 298(5):737-48. PubMed ID: 10801345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R17 RNA replicase. IV. Rifamycin sensitive component of the replicase.
    Igarashi SJ
    J Biochem; 1973 Jan; 73(1):123-30. PubMed ID: 4570367
    [No Abstract]   [Full Text] [Related]  

  • 11. Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins.
    Artsimovitch I; Vassylyeva MN; Svetlov D; Svetlov V; Perederina A; Igarashi N; Matsugaki N; Wakatsuki S; Tahirov TH; Vassylyev DG
    Cell; 2005 Aug; 122(3):351-63. PubMed ID: 16096056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective binding of oligodeoxyribonucleotides with Escherichia coli RNA-polymerase and their effect on DNA-dependent RNA synthesis].
    Savinkova LK; Knorre VL; Salganic RI
    Mol Biol (Mosk); 1984; 18(3):637-42. PubMed ID: 6206389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance in inhibitors of RNA polymerase in actinomycetes which produce them.
    Blanco MG; Hardisson C; Salas JA
    J Gen Microbiol; 1984 Nov; 130(11):2883-91. PubMed ID: 6084703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide.
    Kono Y
    J Biochem; 1982 Jan; 91(1):381-95. PubMed ID: 6279585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of rifamycin derivatives on RNA polymerase of human leukemic lymphocytes.
    Tsai MJ; Saunders GF
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2072-6. PubMed ID: 4516206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A derivative of rifamycin SV inhibiting rifampicin-resistant RNA polymerase of Escherichia coli.
    Nikiforov VG; Trapkova AA; Gragerov AI; Maslin DN
    FEBS Lett; 1982 Dec; 150(2):416-8. PubMed ID: 6761147
    [No Abstract]   [Full Text] [Related]  

  • 17. Homology modeling of wild-type, D516V, and H526L Mycobacterium tuberculosis RNA polymerase and their molecular docking study with inhibitors.
    Josa D; da Cunha EF; Ramalho TC; Souza TC; Caetano MS
    J Biomol Struct Dyn; 2008 Feb; 25(4):373-6. PubMed ID: 18092831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Formation of specific T3-RNA-polymerase complexes with oligoribonucleotides and inhibition of DNA-dependent RNA synthesis].
    Efimova LIu; Savinkova LK; Knorre VL; Salganik RI; Mikhel' Z
    Mol Biol (Mosk); 1980; 14(4):734-42. PubMed ID: 6158671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases.
    Czerwonka D; Domagalska J; Pyta K; Kubicka MM; Pecyna P; Gajecka M; Przybylski P
    Eur J Med Chem; 2016 Jun; 116():216-221. PubMed ID: 27061985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu-induced rifamycin-resistant mutations not located in the rpoB gene of Escherichia coli.
    Kollenda MC; Kamp D; Hartmann GR
    Mol Gen Genet; 1986 Jul; 204(1):192-4. PubMed ID: 3528757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.